Beloderm ointment for external use 0.05% tube 30 g

Beloderm ointment for external use is indicated for the treatment of dermatoses sensitive to potent GCS therapy, such as psoriasis, and the initial treatment of severe atopic eczema.

Composition

Active ingredient: betamethasone;

1 g of ointment contains 0.640 mg of betamethasone dipropionate, which corresponds to 0.500 mg of betamethasone;

Excipients: mineral oil, white soft paraffin.

Contraindication

Hypersensitivity to betamethasone or to other corticosteroids, or to any of the other ingredients of the drug.

Viral infections, including post-vaccination reactions and chickenpox; viral skin infections (e.g. herpes simplex, shingles, chickenpox); acne rosacea; rosacea-like (perioral) dermatitis; bacterial dermatoses, including tuberculosis and syphilis of the skin; fungal diseases, ophthalmological diseases (Beloderm, not intended for ophthalmic use); do not use under occlusive dressings (casts)

Special care should be taken when applying the ointment to the skin of the face.

Do not allow the drug to get into the eyes or mucous membranes.

Do not use in the first trimester of pregnancy.

Prolonged treatment and/or application to large skin surfaces should be avoided as absorption of the active substance is possible.

Method of application

Apply a sufficient amount of ointment in a thin layer to completely cover the affected areas of the skin and gently rub into the skin. As the condition improves, the frequency of applications can be reduced.

Prolonged use of Beloderm or application of the ointment to large areas (more than 20% of the body surface) should be avoided. This also applies to treatment of more than 10% of the body surface for more than one week. After improvement of the clinical picture, the use of a weak GCS is often recommended.

Application features

Pregnant women

The drug should not be used in the first trimester of pregnancy, as the safety of topical corticosteroids for pregnant women has not been established.

Children

Not recommended for use.

Drivers

Does not affect.

Overdose

Excessive or prolonged use of topical corticosteroids may cause pituitary-adrenal suppression, leading to secondary adrenal insufficiency and symptoms of hypercorticism, including Cushing's syndrome. Acute symptoms of hypercorticism are usually reversible.

In case of overdose, appropriate symptomatic treatment is indicated. If necessary, correction of electrolyte balance should be carried out. In case of chronic toxic effects, gradual withdrawal of corticosteroids is recommended.

Side effects

Burning, itching, irritation, dry skin, folliculitis, hypertrichosis, acne-like rashes, hypopigmentation, acne on the background of steroid use, rosacea-like (perioral) dermatitis.

Interaction

Due to the presence of white soft paraffin and mineral oil as excipients, treatment in the anogenital area may damage the structure of latex condoms and reduce their safety when used during treatment.

Storage conditions

Store at a temperature not exceeding 25 °C. Do not freeze.

Keep out of reach of children.

Shelf life - 4 years.